Catharina Larsson Selected Research

Parathyroid Neoplasms (Parathyroid Neoplasm)

1/2018	Molecular profiles of oxyphilic and chief cell parathyroid adenoma.
3/2015	Tumour nuclear oestrogen receptor beta 1 correlates inversely with parathyroid tumour weight.
8/2013	Inhibition of parathyroid hormone secretion by caffeine in human parathyroid cells.
12/2012	Evidence of a functional estrogen receptor in parathyroid adenomas.
1/2012	Genome-wide and locus specific alterations in CDC73/HRPT2-mutated parathyroid tumors.
1/2012	Prolactin receptor in primary hyperparathyroidism--expression, functionality and clinical correlations.
1/2011	Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.
10/2010	Lack of S37A CTNNB1/β-catenin mutations in a Swedish cohort of 98 parathyroid adenomas.
3/2010	Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
2/2009	Loss of expression for the Wnt pathway components adenomatous polyposis coli and glycogen synthase kinase 3-beta in parathyroid carcinomas.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catharina Larsson Research Topics

Disease

92	Neoplasms (Cancer) 06/2022 - 06/2002
17	Adenoma (Adenomas) 06/2022 - 09/2002
17	Thyroid Neoplasms (Thyroid Cancer) 03/2022 - 09/2002
13	Follicular Adenocarcinoma 06/2022 - 04/2003
13	Parathyroid Neoplasms (Parathyroid Neoplasm) 01/2018 - 10/2003
12	Carcinoma (Carcinomatosis) 05/2021 - 09/2002
11	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2005
11	Pheochromocytoma 01/2019 - 08/2002
10	Paraganglioma (Paragangliomas) 10/2020 - 07/2002
10	Carcinogenesis 01/2020 - 04/2003
6	Adrenocortical Carcinoma 05/2022 - 10/2011
6	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 09/2021 - 05/2013
4	Neuroblastoma 01/2021 - 07/2008
4	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2019 - 01/2013
4	Primary Hyperparathyroidism 05/2016 - 01/2006
4	Papillary Thyroid Cancer 01/2015 - 04/2003
4	Anaplastic Thyroid Carcinoma 11/2014 - 04/2003
3	Merkel Cell Carcinoma 01/2020 - 02/2014
3	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2016 - 02/2009
3	Leukemia 01/2013 - 09/2008
3	Hyperparathyroidism 01/2012 - 10/2003
3	Sarcoma (Soft Tissue Sarcoma) 09/2008 - 01/2005
3	Prostatic Neoplasms (Prostate Cancer) 02/2006 - 04/2003
2	Uterine Cervical Dysplasia 05/2017 - 11/2009
2	Infections 02/2014 - 11/2009
2	Papillary Carcinoma 04/2012 - 10/2010
2	T-Cell Leukemia (Leukemia, T Cell) 07/2011 - 04/2009
2	follicular Thyroid cancer 10/2008 - 03/2006
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 09/2007 - 03/2005
2	Chromosome Aberrations (Chromosome Abnormalities) 02/2006 - 06/2002
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2006 - 08/2002
2	Malignant Fibrous Histiocytoma 04/2004 - 09/2003
2	Synovial Sarcoma (Synovioma) 04/2003 - 06/2002
1	von Hippel-Lindau Disease (von Hippel Lindau Disease) 01/2022
1	Islet cell tumor syndrome 01/2019
1	Skin Neoplasms (Skin Cancer) 11/2018
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2017
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2017
1	Testicular Germ Cell Tumor 01/2017
1	Hypoxia (Hypoxemia) 05/2016

Drug/Important Bio-Agent (IBA)

27	Proteins (Proteins, Gene)FDA Link 04/2022 - 09/2003
18	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2022 - 11/2009
18	Messenger RNA (mRNA)IBA 05/2022 - 09/2002
12	RacivirIBA 06/2022 - 04/2003
12	MicroRNAs (MicroRNA)IBA 09/2021 - 08/2010
11	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2002
6	CatecholaminesIBA 10/2020 - 08/2002
5	RNA (Ribonucleic Acid)IBA 05/2021 - 06/2002
5	Pharmaceutical PreparationsIBA 07/2019 - 04/2009
5	CalciumIBA 01/2018 - 11/2006
5	Biological ProductsIBA 08/2013 - 02/2005
4	Imatinib Mesylate (Gleevec)FDA Link 09/2021 - 04/2014
3	CateninsIBA 05/2022 - 10/2010
3	Transcription Factors (Transcription Factor)IBA 03/2022 - 12/2012
3	EnzymesIBA 01/2020 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 10/2017 - 04/2012
3	hydrogen sulfite (bisulfite)IBA 06/2013 - 05/2008
3	Insulin-Like PeptidesIBA 01/2013 - 01/2005
3	Complementary DNA (cDNA)IBA 02/2006 - 12/2002
2	ParaffinIBA 05/2021 - 03/2002
2	Uridine Monophosphate (UMP)IBA 09/2019 - 01/2018
2	Chloride Channels (Chloride Channel)IBA 07/2019 - 08/2014
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 04/2014
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2017 - 01/2016
2	SurvivinIBA 10/2016 - 02/2014
2	AldosteroneIBA 04/2014 - 07/2009
2	trichostatin A (A 300)IBA 01/2013 - 07/2008
2	Hormones (Hormone)IBA 01/2012 - 01/2011
2	PPAR gammaIBA 09/2008 - 09/2003
2	Cyclin D1IBA 09/2008 - 03/2005
2	AntigensIBA 03/2005 - 06/2002
2	SYT-SSX fusion proteinIBA 04/2003 - 06/2002
1	Oxygen (Dioxygen)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 05/2021
1	RNA Splicing FactorsIBA 01/2021
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	Bortezomib (Velcade)FDA Link 10/2019
1	pevonedistatIBA 10/2019
1	NEDD8 ProteinIBA 10/2019
1	Proteasome InhibitorsIBA 10/2019
1	ElementsIBA 01/2019
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	Chromogranin BIBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 01/2018
1	ProteomeIBA 01/2018
1	NF-kappa B (NF-kB)IBA 01/2017
1	Differentiation AntigensIBA 01/2017
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2017
1	Mitotane (Lysodren)FDA Link 01/2017
1	CytochromesIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	human CYP2A7 protein (CYP2A7)IBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 10/2016
1	25-hydroxyvitamin DIBA 05/2016
1	Phosphotransferases (Kinase)IBA 05/2016

Therapy/Procedure

10	Therapeutics 03/2022 - 09/2008
3	Drug Therapy (Chemotherapy) 01/2019 - 09/2008